Eun Taeg Kim

8PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 11, 2025
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy.

Ji Hyun Kim, Eun Taeg Kim, Heon Jong Yoo

|Mar 13, 2025
The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer.

Ji Hyun Kim, Se Ik Kim, Eun Taeg Kim

|Nov 26, 2024
Clinical Outcomes of Poly(ADP-Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea.

Hyeong In Ha, Hyung Joon Yoon, Changho Song

|Nov 11, 2024
The Efficacy and Safety of Folate Receptor α-Targeted Antibody-Drug Conjugate Therapy in Patients With High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers: A Systematic Review and Meta-Analysis.

Eun Taeg Kim, Ji Hyun Kim, Eun Young Park

|Oct 24, 2024
Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancer.

Se Ik Kim, Ji Hyun Kim, Eun Young Park

|Jul 13, 2024
Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors.

Ji Hyun Kim, Eun Taeg Kim, Se Ik Kim

Pageof 2

Frequent Collaborators

4 joint publications

Myong Cheol Lim

2 joint publications

Ki Hyung Kim

2 joint publications

Se Ik Kim

2 joint publications

Myong Cheol Lim